Viewing Study NCT02750592


Ignite Creation Date: 2025-12-24 @ 3:32 PM
Ignite Modification Date: 2026-02-22 @ 7:04 AM
Study NCT ID: NCT02750592
Status: COMPLETED
Last Update Posted: 2019-09-09
First Post: 2016-04-04
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Study of Efficacy and Safety of Secukinumab in Japanese Patients With Active Ankylosing Spondylitis
Sponsor: Novartis Pharmaceuticals
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Ankylosing Spondylitis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Ankylosing Spondylitis View
None secukinumab View
None AIN457H View
None SpondyloArthritis View